Skip to main content
Top
Published in: Journal of Cancer Survivorship 1/2011

Open Access 01-03-2011

The relation between arm/shoulder problems and quality of life in breast cancer survivors: a cross-sectional and longitudinal study

Authors: Inger-Lise Nesvold, Kristin Valborg Reinertsen, Sophie D. Fosså, Alv A. Dahl

Published in: Journal of Cancer Survivorship | Issue 1/2011

Login to get access

Abstract

Background

This cross-sectional and longitudinal study of breast cancer survivors (BCSs) examines the associations between arm/shoulder problems (ASPs), which consist of pain, restricted mobility and lymphedema, and different aspects of quality of life (QoL).

Methods

BCSs who had breast surgery, axillary lymph node dissection and radiotherapy (n = 255) were examined in 2004 (mean 4.1 years post-surgery) and a sub-sample (n = 187) was re-examined in 2007. ASPs was rated clinically in 2004 and by self-report (EORTC BR23) in 2004 and 2007. QoL was self-reported with The Short Form-36 (SF-36) and The Impact of Cancer scale (IOC).

Results

In 2004 BCSs with ASPs showed significantly poorer mean scores in most SF-36 domains compared to those without. No group differences were observed for positive IOC domains, while BCSs with ASPs showed significantly poorer mean scores in the negative ones. BCSs with clinically defined movement restriction showed significantly poorer SF-36 and negative IOC mean scores than those with clinically defined lymphedema. The longitudinal sub-study of self-rated pain, restricted mobility and lymphedema showed significant changes over time only for negative IOC domains in the pain group. Self-rated restricted mobility and lymphedema were significantly associated with most SF-36 domains both in 2004 and 2007, while few were associated with pain. Self-rated pain and restricted mobility showed significant associations with negative IOC domains.

Implications for cancer survivors

Not only lymphedema, but pain and restricted mobility in the arm/shoulder are significantly associated with poor QoL in BCSs at long-term. These problems should be diagnosed and treated in order to improve QoL.
Literature
1.
go back to reference Ahmed RL, Prizment A, Lazovich DA, Schmitz KH, Folsom AF. Lymphedema and quality of life in breast cancer survivors: The Iowa Women’s Health Study. J Clin Oncol. 2008;26:5689–96.CrossRefPubMed Ahmed RL, Prizment A, Lazovich DA, Schmitz KH, Folsom AF. Lymphedema and quality of life in breast cancer survivors: The Iowa Women’s Health Study. J Clin Oncol. 2008;26:5689–96.CrossRefPubMed
2.
go back to reference Norman SA, Russel Locario A, Potashnik SL, Simoes Torpey HA, Kallan MJ, Weber AL, et al. Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms. J Clin Oncol. 2009;27:390–97.CrossRefPubMed Norman SA, Russel Locario A, Potashnik SL, Simoes Torpey HA, Kallan MJ, Weber AL, et al. Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms. J Clin Oncol. 2009;27:390–97.CrossRefPubMed
3.
go back to reference Nesvold IL, Dahl AA, Løkkevik E, Mengshoel AM, Fosså SD. Arm and shoulder morbidity in breast cancer patients after breast-conserving therapy versus mastectomy. Acta Oncol. 2008;47:835–42.CrossRefPubMed Nesvold IL, Dahl AA, Løkkevik E, Mengshoel AM, Fosså SD. Arm and shoulder morbidity in breast cancer patients after breast-conserving therapy versus mastectomy. Acta Oncol. 2008;47:835–42.CrossRefPubMed
4.
go back to reference Peuckmann V, Ekholm O, Rasmussen NK, Groenvold M, Christiansen P, Møller S, et al. Chronic pain and other sequelae in long-term breast cancer survivors: nationwide survey in Denmark. Eur J Pain. 2009;13:478–85.CrossRefPubMed Peuckmann V, Ekholm O, Rasmussen NK, Groenvold M, Christiansen P, Møller S, et al. Chronic pain and other sequelae in long-term breast cancer survivors: nationwide survey in Denmark. Eur J Pain. 2009;13:478–85.CrossRefPubMed
5.
go back to reference Sagen A, Kåresen R, Risberg MA. Changes in arm morbidities and health-related quality of life after breast cancer surgery—a five year follow-up study. Acta Oncol. 2009;48:1102–10.CrossRefPubMed Sagen A, Kåresen R, Risberg MA. Changes in arm morbidities and health-related quality of life after breast cancer surgery—a five year follow-up study. Acta Oncol. 2009;48:1102–10.CrossRefPubMed
6.
go back to reference Montazeri A. Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007. J Exp Clin Ca Res. 2008;27:1–31.CrossRef Montazeri A. Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007. J Exp Clin Ca Res. 2008;27:1–31.CrossRef
7.
go back to reference Engel J, Kerr J, Schlesinger-Raab A, Sauer H, Hölzel D. Axillary surgery severely affects quality of life: results of a 5-year prospective study in breast cancer patients. Breast Cancer Res Treat. 2003;79:47–57.CrossRefPubMed Engel J, Kerr J, Schlesinger-Raab A, Sauer H, Hölzel D. Axillary surgery severely affects quality of life: results of a 5-year prospective study in breast cancer patients. Breast Cancer Res Treat. 2003;79:47–57.CrossRefPubMed
8.
go back to reference Kwan W, Jackson J, Weir LM, Dingee C, McGregor Greg, Olivotto IA. Chronic arm morbidity after curative breast cancer treatment: prevalence and impact on quality of life. J Clin Oncol. 2002;20:4242–48.CrossRefPubMed Kwan W, Jackson J, Weir LM, Dingee C, McGregor Greg, Olivotto IA. Chronic arm morbidity after curative breast cancer treatment: prevalence and impact on quality of life. J Clin Oncol. 2002;20:4242–48.CrossRefPubMed
9.
go back to reference Chachaj A, Malyszczak K, Pyszel K, Lukas J, Tarkowski R, Pudelko M, et al. Physical and psychological impairments of women with upper limb lymphedema following breast cancer treatment. Psycho-Oncol. 2010;19:299–305.CrossRef Chachaj A, Malyszczak K, Pyszel K, Lukas J, Tarkowski R, Pudelko M, et al. Physical and psychological impairments of women with upper limb lymphedema following breast cancer treatment. Psycho-Oncol. 2010;19:299–305.CrossRef
10.
go back to reference Pyszel A, Malyszczak K, Pyszel K, Andrejak R, Szuba A. Disability, psychological distress and quality of life in breast cancer survivors with arm lymphedema. Lymphology. 2006;39:185–92.PubMed Pyszel A, Malyszczak K, Pyszel K, Andrejak R, Szuba A. Disability, psychological distress and quality of life in breast cancer survivors with arm lymphedema. Lymphology. 2006;39:185–92.PubMed
11.
go back to reference Bentzen SM, Overgaard AM, Thames HD. Fractionation sensitivity of a functional endpoint: impaired shoulder movement after post-mastectomy radiotherapy. Int J Radiat Oncol Biol Phys. 1989;17:531–37.CrossRefPubMed Bentzen SM, Overgaard AM, Thames HD. Fractionation sensitivity of a functional endpoint: impaired shoulder movement after post-mastectomy radiotherapy. Int J Radiat Oncol Biol Phys. 1989;17:531–37.CrossRefPubMed
12.
go back to reference Mols F, Vingerthoets AJ, Coebergh JW, van de Poll-Franse LV. Quality of life among long-term breast cancer survivors: a systematic review. Eur J Cancer. 2005;41:2613–19.CrossRefPubMed Mols F, Vingerthoets AJ, Coebergh JW, van de Poll-Franse LV. Quality of life among long-term breast cancer survivors: a systematic review. Eur J Cancer. 2005;41:2613–19.CrossRefPubMed
13.
go back to reference Zebrack BJ, Ganz PA, Bernaards CA, Petersen L, Abraham L. Assessing the impact of cancer: development of a new instrument for long-term survivors. Psycho-Onco. 2006;15:407–21.CrossRef Zebrack BJ, Ganz PA, Bernaards CA, Petersen L, Abraham L. Assessing the impact of cancer: development of a new instrument for long-term survivors. Psycho-Onco. 2006;15:407–21.CrossRef
14.
go back to reference Pearce NJM, Sanson-Fisher R, Campell HS. Measuring quality of life in cancer survivors:a methodological review of exisaitng scale. Psycho-Oncol. 2008;17:629–40.CrossRef Pearce NJM, Sanson-Fisher R, Campell HS. Measuring quality of life in cancer survivors:a methodological review of exisaitng scale. Psycho-Oncol. 2008;17:629–40.CrossRef
15.
go back to reference Reinertsen KV, Cvankarova M, Wist E, Fosså SD, et al. Thyroid function in women after multimodal treatment for breast cancer stage II/III: comparison with controls from a population sample. Int J Radiat Oncol Biol Phys. 2009;75:764–70.CrossRefPubMed Reinertsen KV, Cvankarova M, Wist E, Fosså SD, et al. Thyroid function in women after multimodal treatment for breast cancer stage II/III: comparison with controls from a population sample. Int J Radiat Oncol Biol Phys. 2009;75:764–70.CrossRefPubMed
16.
go back to reference Karges JR, Mark BE, Stikeleather SJ, Worrell TW. Concurrent validity of upper-extremity volume estimates: comparison of calculated volume derived from girth measurements and water displacement volume. Phys Therapy. 2003;83:134–45. Karges JR, Mark BE, Stikeleather SJ, Worrell TW. Concurrent validity of upper-extremity volume estimates: comparison of calculated volume derived from girth measurements and water displacement volume. Phys Therapy. 2003;83:134–45.
17.
go back to reference Nesvold IL, Fosså SD, Naume B, Dahl AA. Kwan´s arm problem scale: psychometric examination in a sample of stage II breast cancer survivors. Breast Cancer Res Treat. 2008;117:281–88.CrossRefPubMed Nesvold IL, Fosså SD, Naume B, Dahl AA. Kwan´s arm problem scale: psychometric examination in a sample of stage II breast cancer survivors. Breast Cancer Res Treat. 2008;117:281–88.CrossRefPubMed
18.
go back to reference Sprangers MAG, Groenvold M, Arraras JI, Franklin J, te Velde A, Muller M, et al. The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol. 1996;14:2756–68.PubMed Sprangers MAG, Groenvold M, Arraras JI, Franklin J, te Velde A, Muller M, et al. The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol. 1996;14:2756–68.PubMed
19.
go back to reference Ware JE, Snow KK, Kosinski M, et al. SF-36® health survey: manual and interpretation guide. Lincoln: Quality Metric Inc; 2000. Ware JE, Snow KK, Kosinski M, et al. SF-36® health survey: manual and interpretation guide. Lincoln: Quality Metric Inc; 2000.
20.
go back to reference Ware JE, Gandek B, Kosinski M, et al. The equivalence of the SF-36 summary health scores estimating using standard and country-specific algorithms in 10 countries: results from the IQOLA project. J Clin Epidemiol. 1998;11:1167–70.CrossRef Ware JE, Gandek B, Kosinski M, et al. The equivalence of the SF-36 summary health scores estimating using standard and country-specific algorithms in 10 countries: results from the IQOLA project. J Clin Epidemiol. 1998;11:1167–70.CrossRef
21.
go back to reference Lipsey MW, Wilson DB. Practical meta-analysis Thousand Oaks. CA: Sage; 2001. Lipsey MW, Wilson DB. Practical meta-analysis Thousand Oaks. CA: Sage; 2001.
22.
go back to reference Nakagawa S, Cuthill IC. Effect size, confidence interval and statistical significance: a practical guide for biologists. Biol Rev. 2007;82:591–605.CrossRefPubMed Nakagawa S, Cuthill IC. Effect size, confidence interval and statistical significance: a practical guide for biologists. Biol Rev. 2007;82:591–605.CrossRefPubMed
23.
go back to reference Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale: Earlbaum; 1988. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale: Earlbaum; 1988.
24.
go back to reference Schwartz CE, Bode R, Repucci N, Becker J, Sprangers MAG, Fayers PM. The clinical significance of adaptation to changing health: a meta-analysis of response shift. Quality of Life Res. 2006;15:1533–50.CrossRef Schwartz CE, Bode R, Repucci N, Becker J, Sprangers MAG, Fayers PM. The clinical significance of adaptation to changing health: a meta-analysis of response shift. Quality of Life Res. 2006;15:1533–50.CrossRef
25.
go back to reference Thomas-Maclean RL, Hack T, Kwan W, Towers A, Miedema B, Tilley A. Arm morbidity and disability after breast cancer: new directions of care. Oncol Nurs Forum. 2008;35:65–71.CrossRefPubMed Thomas-Maclean RL, Hack T, Kwan W, Towers A, Miedema B, Tilley A. Arm morbidity and disability after breast cancer: new directions of care. Oncol Nurs Forum. 2008;35:65–71.CrossRefPubMed
26.
go back to reference Smoot B, Wong J, Cooper B, Wanec L, Topp K, Byl N, et al. Upper extremity impairments in women with or without lymphedema following breast cancer treatment. J Cancer Surviv 2010;4:167–78. Smoot B, Wong J, Cooper B, Wanec L, Topp K, Byl N, et al. Upper extremity impairments in women with or without lymphedema following breast cancer treatment. J Cancer Surviv 2010;4:167–78.
27.
go back to reference Kuehn T, Klauss W, Darsow M, Regele S, Flock F, Kreienberg R, et al. Long-term morbidity following axillary dissection in breast cancer patients—clinical assessment, significance for life quality and the impact of demographic, oncologic and therapeutic factors. Breast Cancer Res Treat. 2000;64:275–86.CrossRefPubMed Kuehn T, Klauss W, Darsow M, Regele S, Flock F, Kreienberg R, et al. Long-term morbidity following axillary dissection in breast cancer patients—clinical assessment, significance for life quality and the impact of demographic, oncologic and therapeutic factors. Breast Cancer Res Treat. 2000;64:275–86.CrossRefPubMed
28.
go back to reference Lauridsen MC, Overgaard M, Overgaard J, Hessow IB, Christiansen P. Shoulder disability and late symptoms following surgery for early breast cancer. Acta Oncol. 2008;47:569–75.CrossRefPubMed Lauridsen MC, Overgaard M, Overgaard J, Hessow IB, Christiansen P. Shoulder disability and late symptoms following surgery for early breast cancer. Acta Oncol. 2008;47:569–75.CrossRefPubMed
29.
go back to reference Levangie PK, Drouin J. Magnitude of late effects of breast cancer treatment on shoulder function: a systematic review. Breast Cancer Res Treat. 2009;116:1–15.CrossRefPubMed Levangie PK, Drouin J. Magnitude of late effects of breast cancer treatment on shoulder function: a systematic review. Breast Cancer Res Treat. 2009;116:1–15.CrossRefPubMed
30.
go back to reference Hopwood P, Haviland JS, Sumo G, Mills J, Bliss JM, Yarnold JR. Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials. Lancet Oncol. 2010;11:231–40.CrossRefPubMed Hopwood P, Haviland JS, Sumo G, Mills J, Bliss JM, Yarnold JR. Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials. Lancet Oncol. 2010;11:231–40.CrossRefPubMed
31.
go back to reference Liu C, Guo Y, Shi J, Sheng Y. Late morbidity associated with a tumour-negative sentinel lymph-node biopsy in primary breast cancer patients: a systematic review. Eur J Cancer. 2009;45:1560–8.CrossRefPubMed Liu C, Guo Y, Shi J, Sheng Y. Late morbidity associated with a tumour-negative sentinel lymph-node biopsy in primary breast cancer patients: a systematic review. Eur J Cancer. 2009;45:1560–8.CrossRefPubMed
32.
go back to reference Vignes S, Arrault M, Dupuy A. Factors associated with increased breast cancer-related lymphedema volume. Acta Oncol. 2007;46:1138–42.CrossRefPubMed Vignes S, Arrault M, Dupuy A. Factors associated with increased breast cancer-related lymphedema volume. Acta Oncol. 2007;46:1138–42.CrossRefPubMed
33.
go back to reference Koul R, Dufan T, Russell C, Guenther W, Nugent Z, Sun X, et al. Efficacy of complete decongestive therapy and manual lymphatic drainage on treatment-related lymphedema in breast cancer. Int J Radiat Oncol Biol Phys. 2007;67:841–46.CrossRefPubMed Koul R, Dufan T, Russell C, Guenther W, Nugent Z, Sun X, et al. Efficacy of complete decongestive therapy and manual lymphatic drainage on treatment-related lymphedema in breast cancer. Int J Radiat Oncol Biol Phys. 2007;67:841–46.CrossRefPubMed
34.
go back to reference Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst. 2006;98:599–609.CrossRefPubMed Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst. 2006;98:599–609.CrossRefPubMed
35.
go back to reference Purushotham AD, Upponi S, Klevesath MB, Bobrow L, Millar K, Myles JP, et al. Morbidity after sentinel lymph node biopsy in primary breast cancer: results form a randomized controlled trial. J Clin Oncol. 2005;23:4312–21.CrossRefPubMed Purushotham AD, Upponi S, Klevesath MB, Bobrow L, Millar K, Myles JP, et al. Morbidity after sentinel lymph node biopsy in primary breast cancer: results form a randomized controlled trial. J Clin Oncol. 2005;23:4312–21.CrossRefPubMed
36.
go back to reference McNeely ML, Campbell K, Ospina M, Rowe BH, Dabbs K, Klassen TP, et al. Exercise interventions for upper-limb dysfunction due to breast cancer treatment (Review). 2010; The Cochrane Collaboration. McNeely ML, Campbell K, Ospina M, Rowe BH, Dabbs K, Klassen TP, et al. Exercise interventions for upper-limb dysfunction due to breast cancer treatment (Review). 2010; The Cochrane Collaboration.
Metadata
Title
The relation between arm/shoulder problems and quality of life in breast cancer survivors: a cross-sectional and longitudinal study
Authors
Inger-Lise Nesvold
Kristin Valborg Reinertsen
Sophie D. Fosså
Alv A. Dahl
Publication date
01-03-2011
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 1/2011
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-010-0156-4

Other articles of this Issue 1/2011

Journal of Cancer Survivorship 1/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine